Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.41
-0.18 (-1.23%)
Jun 1, 2026, 2:30 PM EDT - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $878.78 million as of June 1, 2026. Its market cap has decreased by -34.35% in one year.
Market Cap
878.78M
Enterprise Value
-57.25M
1-Year Change
-34.35%
Ranking
Category
Stock Price
$14.41
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $878.78M, an increase of 43.19%. That is a compound annual growth rate of 7.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 889.76M | 7.20% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 949.84M |
| Sana Biotechnology | 918.36M |
| Kura Oncology | 905.50M |
| Arbutus Biopharma | 900.77M |
| ARS Pharmaceuticals | 900.68M |
| Annexon | 888.03M |
| Xencor | 880.80M |
| Bright Minds Biosciences | 878.77M |